Wen-Chih Wu1, Lan Jiang2, Peter D Friedmann3, Amal Trivedi4. 1. Center of Innovation in Long-Term Services and Supports, Providence Veterans Affairs Medical Center, Providence, RI; Department of Medicine, Alpert Medical School of Brown University, Providence, RI; Medical Service, Providence Veterans Affairs, Providence, RI. Electronic address: Wen-Chih.Wu@va.gov. 2. Center of Innovation in Long-Term Services and Supports, Providence Veterans Affairs Medical Center, Providence, RI. 3. Center of Innovation in Long-Term Services and Supports, Providence Veterans Affairs Medical Center, Providence, RI; Department of Medicine, Alpert Medical School of Brown University, Providence, RI; Department of Community Health, Brown University, Providence, RI. 4. Center of Innovation in Long-Term Services and Supports, Providence Veterans Affairs Medical Center, Providence, RI; Department of Community Health, Brown University, Providence, RI; Medical Service, Providence Veterans Affairs, Providence, RI.
Abstract
BACKGROUND: The few available studies of the Centers for Medicare and Medicaid Services Hospital Inpatient Quality Reporting (IQR) care process indicators have not linked receipt of recommended care processes in heart failure (HF) with lower mortality. Because the Veterans Health Administration (VHA) also tracks hospital inpatient quality reporting indicators, in addition to VHA-specific inpatient (pneumococcal and influenza vaccination) and outpatient (angiotensin-converting enzyme inhibitor [ACEI] or angiotensin receptor blocker [ARB] use for left ventricular [LV] dysfunction and LV function documentation) care process indicators, we examined the association between receipt of these care processes and 30-day and 1-year mortality. METHODS: Retrospective study of 107,045 patients with HF treated at 128 VHA hospitals between 2001 and 2007 and followed up through 2008. We assessed the relationship between receipt of each HF care process and death at 30 days (inpatients only) and 1 year (all patients), using generalized estimating equations to adjust for clinical characteristics and clustering within hospitals. RESULTS: Overall, inpatient/outpatient use of ACEI/ARB and receipt of pneumococcal or influenza vaccinations were related to lower risks of 30-day and/or 1-year mortality (adjusted odds ratios 0.51-0.77 for vaccinations and 0.60-0.78 for ACEI/ARB use). Conversely, discharge instructions, inpatient/outpatient LV function assessment, or weight instructions before admission were either not related or related to a slightly increase in mortality. Stratified analyses by various mortality risk subgroups did not reveal discernable "dose-response" relationship between mortality risk stratification and the association of care process and mortality. CONCLUSIONS: Receipt of care processes related to recommended medications and vaccinations were associated with lower 30-day and/or 1-year risk-adjusted mortality in patients with HF. Receipt of care processes that assess patient counseling or chart documentation was not related to lower mortality. Published by Elsevier Inc.
BACKGROUND: The few available studies of the Centers for Medicare and Medicaid Services Hospital Inpatient Quality Reporting (IQR) care process indicators have not linked receipt of recommended care processes in heart failure (HF) with lower mortality. Because the Veterans Health Administration (VHA) also tracks hospital inpatient quality reporting indicators, in addition to VHA-specific inpatient (pneumococcal and influenza vaccination) and outpatient (angiotensin-converting enzyme inhibitor [ACEI] or angiotensin receptor blocker [ARB] use for left ventricular [LV] dysfunction and LV function documentation) care process indicators, we examined the association between receipt of these care processes and 30-day and 1-year mortality. METHODS: Retrospective study of 107,045 patients with HF treated at 128 VHA hospitals between 2001 and 2007 and followed up through 2008. We assessed the relationship between receipt of each HF care process and death at 30 days (inpatients only) and 1 year (all patients), using generalized estimating equations to adjust for clinical characteristics and clustering within hospitals. RESULTS: Overall, inpatient/outpatient use of ACEI/ARB and receipt of pneumococcal or influenza vaccinations were related to lower risks of 30-day and/or 1-year mortality (adjusted odds ratios 0.51-0.77 for vaccinations and 0.60-0.78 for ACEI/ARB use). Conversely, discharge instructions, inpatient/outpatient LV function assessment, or weight instructions before admission were either not related or related to a slightly increase in mortality. Stratified analyses by various mortality risk subgroups did not reveal discernable "dose-response" relationship between mortality risk stratification and the association of care process and mortality. CONCLUSIONS: Receipt of care processes related to recommended medications and vaccinations were associated with lower 30-day and/or 1-year risk-adjusted mortality in patients with HF. Receipt of care processes that assess patient counseling or chart documentation was not related to lower mortality. Published by Elsevier Inc.
Authors: H M Krumholz; D W Baker; C M Ashton; S B Dunbar; G C Friesinger; E P Havranek; M A Hlatky; M Konstam; D L Ordin; I L Pina; B Pitt; J A Spertus Journal: Circulation Date: 2000-03-28 Impact factor: 29.690
Authors: Eugene S Chung; Donald E Casey; Cheryl Bartone; Santosh Menon; Syed Saghir; Anubhav Mital; Dean J Kereiakes Journal: Am J Med Qual Date: 2008 May-Jun Impact factor: 1.852
Authors: M D Flather; S Yusuf; L Køber; M Pfeffer; A Hall; G Murray; C Torp-Pedersen; S Ball; J Pogue; L Moyé; E Braunwald Journal: Lancet Date: 2000-05-06 Impact factor: 79.321
Authors: Joseph S Ross; Charles Maynard; Harlan M Krumholz; Haili Sun; John S Rumsfeld; Sharon-Lise T Normand; Yun Wang; Stephan D Fihn Journal: Med Care Date: 2010-07 Impact factor: 2.983
Authors: Gregg C Fonarow; Nancy M Albert; Anne B Curtis; Mihai Gheorghiade; J Thomas Heywood; Yang Liu; Mandeep R Mehra; Christopher M O'Connor; Dwight Reynolds; Mary Norine Walsh; Clyde W Yancy Journal: Circulation Date: 2011-04-04 Impact factor: 29.690
Authors: Elke Platz; Pardeep S Jhund; Brian L Claggett; Marc A Pfeffer; Karl Swedberg; Christopher B Granger; Salim Yusuf; Scott D Solomon; John J McMurray Journal: Eur J Heart Fail Date: 2017-09-04 Impact factor: 15.534
Authors: Douglas Berger; Gwen T Lapham; Susan M Shortreed; Eric J Hawkins; Anna D Rubinsky; Emily C Williams; Carol E Achtmeyer; Daniel R Kivlahan; Katharine A Bradley Journal: J Gen Intern Med Date: 2017-10-18 Impact factor: 5.128
Authors: Matthew T Mefford; Ran Liu; Katia Bruxvoort; Lei Qian; Jonathan M Doris; Sandra Y Koyama; Hung Fu Tseng; Kristi Reynolds Journal: J Gen Intern Med Date: 2021-08-11 Impact factor: 6.473
Authors: Siva H Yedlapati; Safi U Khan; Swapna Talluri; Ahmed N Lone; Muhammad Zia Khan; Muhammad Shahzeb Khan; Ann M Navar; Martha Gulati; Heather Johnson; Seth Baum; Erin D Michos Journal: J Am Heart Assoc Date: 2021-03-13 Impact factor: 5.501
Authors: Elizabeth T Cafiero-Fonseca; Andrew Stawasz; Sydney T Johnson; Reiko Sato; David E Bloom Journal: PLoS One Date: 2017-10-31 Impact factor: 3.240
Authors: Sanjay Poudel; Fadi Shehadeh; Ioannis M Zacharioudakis; Giannoula S Tansarli; Fainareti N Zervou; Markos Kalligeros; Robertus van Aalst; Ayman Chit; Eleftherios Mylonakis Journal: Open Forum Infect Dis Date: 2019-04-02 Impact factor: 3.835